Differential prognostic impact of <scp> <i>RUNX1</i> </scp> mutations according to frontline therapy in patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia

Published:2022-09-26 Issue:12 Volume:97 Page:1560-1567
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Venugopal Sangeetha¹^ORCID,DiNardo Courtney D.¹^ORCID,Loghavi Sanam²^ORCID,Qiao Wei³,Ravandi Farhad¹^ORCID,Konopleva Marina¹^ORCID,Kadia Tapan¹^ORCID,Bhalla Kapil¹^ORCID,Jabbour Elias¹^ORCID,Issa Ghayas C.¹^ORCID,Macaron Walid¹^ORCID,Daver Naval¹^ORCID,Borthakur Gautam¹^ORCID,Montalban‐Bravo Guillermo¹^ORCID,Yilmaz Musa¹^ORCID,Patel Keyur P.²,Kanagal‐Shamanna Rashmi²^ORCID,Chien Kelly¹^ORCID,Maiti Abhishek¹^ORCID,Kantarjian Hagop¹^ORCID,Short Nicholas J.¹^ORCID

Affiliation:

1. Departments of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA

2. Departments of Hematopathology, and The University of Texas MD Anderson Cancer Center Houston Texas USA

3. Departments of Biostatistics The University of Texas MD Anderson Cancer Center Houston Texas USA

Funder

University of Texas MD Anderson Cancer Center

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26724

Reference26 articles.

1. AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis

2. RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making;Mangan JK;Crit Rev Oncog,2011

3. Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome

4. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder

5. Implications of somatic mutations in the AML1 gene in radiation‐associated and therapy‐related myelodysplastic syndrome/acute myeloid leukemia;Harada H;Blood J Am Soc Hematol,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A CD8+ T cell related immune score predicts survival and refines the risk assessment in acute myeloid leukemia;Frontiers in Immunology;2024-09-12

2. Investigations of the prognostic value of RUNX1 mutation in acute myeloid leukemia patients: Data from a real-world study;Leukemia Research;2024-04

3. A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria;Blood Advances;2024-03-29

4. Under AI’s lens: spotting mutations visually;Blood Advances;2024-02-13

5. Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients;American Journal of Hematology;2023-12-10